Bank7 Corp. Discloses Material Weaknesses in Internal Controls; Auditor Issues Adverse Opinion
summarizeSummary
Bank7 Corp. disclosed multiple material weaknesses in its internal controls, resulting in an adverse auditor opinion, raising significant concerns about financial reporting reliability despite overall loan and deposit growth.
check_boxKey Events
-
Material Weaknesses in Internal Controls
Management identified pervasive material weaknesses in internal control over financial reporting across multiple areas, including deposit operations, related party transactions, reconciliations, financial statement disclosures, segregation of duties, completeness and accuracy of information, and IT general controls.
-
Adverse Auditor Opinion on Internal Controls
RSM US LLP, the independent auditor, issued an adverse opinion on the effectiveness of Bank7 Corp.'s internal control over financial reporting as of December 31, 2025, due to the identified material weaknesses.
-
Mixed Financial Performance
For the year ended December 31, 2025, net income decreased to $43.069 million from $45.698 million in 2024, and basic EPS fell to $4.56 from $4.92. Net interest margin also compressed to 4.94% from 5.11%.
-
Strong Loan and Deposit Growth
Total loans increased by 15.0% to $1.61 billion, and total deposits grew by 12.2% to $1.70 billion as of December 31, 2025, demonstrating significant balance sheet expansion.
auto_awesomeAnalysis
Bank7 Corp. has reported material weaknesses in its internal control over financial reporting as of December 31, 2025, leading its independent registered public accounting firm, RSM US LLP, to issue an adverse opinion on the effectiveness of these controls. The identified weaknesses are pervasive, affecting critical areas such as deposit operations, related party transactions, reconciliations, financial statement disclosures, segregation of duties, completeness and accuracy of information, and IT general controls. This indicates a significant risk that material misstatements in financial statements may not be prevented or detected. While the company reported strong loan and deposit growth for 2025, net income and earnings per share decreased, and net interest margin compressed. The adverse opinion on internal controls is a serious concern for investors, highlighting fundamental issues with financial reporting reliability, despite the company maintaining a 'well-capitalized' status.
At the time of this filing, BSVN was trading at $39.70 on NASDAQ in the Finance sector, with a market capitalization of approximately $375.3M. The 52-week trading range was $32.49 to $50.10. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.